Journal article
AKT promotes rRNA synthesis and cooperates with c-MYC to stimulate ribosome biogenesis in cancer
JC Chan, KM Hannan, K Riddell, PY Ng, A Peck, RS Lee, S Hung, MV Astle, M Bywater, M Wall, G Poortinga, K Jastrzebski, KE Sheppard, BA Hemmings, MN Hall, RW Johnstone, GA McArthur, RD Hannan, RB Pearson
Science Signaling | Published : 2011
Abstract
Precise regulation of ribosome biogenesis is fundamental to maintain normal cell growth and proliferation, and accelerated ribosome biogenesis is associated with malignant transformation. Here, we show that the kinase AKT regulates ribosome biogenesis at multiple levels to promote ribosomal RNA (rRNA) synthesis. Transcription elongation by RNA polymerase I, which synthesizes rRNA, required continuous AKT-dependent signaling, an effect independent of AKT's role in activating the translation-promoting complex mTORC1 (mammalian target of rapamycin complex 1). Sustained inhibition of AKT and mTORC1 cooperated to reduce rRNA synthesis and ribosome biogenesis by additionally limiting RNA polymeras..
View full abstractRelated Projects (3)
Grants
Awarded by Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
Funding Acknowledgements
This work was supported by grants and fellowships from the National Health and Medical Research Council (NHMRC) of Australia to R. D. H. (NHMRC #166908, #400120, and #509088) and to R. B. P. (NHMRC # 509087 and # 400116), Cancer Council Victoria to R. B. P., and Swiss National Science Foundation to M.N.H. R.W.J. is an NHMRC Principal Research Fellow. M. W. is funded by a Clinical Research Fellowship from the Victorian Cancer Agency. This work is supported by NHMRC program and project grants plus grants from the Victorian Cancer Agency and Australian Rotary Health.